[Federal Register: August 10, 2004 (Volume 69, Number 153)]
[Page 48520]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



[Investigation No. 731-TA-130 (Second Review)]

Chloropicrin From China


    On the basis of the record \1\ developed in the subject five-year 
review, the United States International Trade Commission (Commission) 
determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 
U.S.C. 1675(c)) (the Act), that revocation of the antidumping duty 
order on chloropicrin from China would be likely to lead to 
continuation or recurrence of material injury to an industry in the 
United States within a reasonably foreseeable time.

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).


    The Commission instituted this review on March 1, 2004 (69 FR 9638) 
and determined on June 4, 2004 that it would conduct an expedited 
review (69 FR 34402, June 21, 2004).
    The Commission transmitted its determination in this review to the 
Secretary of Commerce on August 3, 2004. The views of the Commission 
are contained in USITC Publication 3712 (August 2004), entitled 
Chloropicrin From China: Investigation No. 731-TA-130 (Second Review).

    By order of the Commission.

    Issued: August 5, 2004.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 04-18249 Filed 8-9-04; 8:45 am]